首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   18367篇
  免费   1563篇
  国内免费   1760篇
  2024年   35篇
  2023年   153篇
  2022年   444篇
  2021年   830篇
  2020年   588篇
  2019年   765篇
  2018年   749篇
  2017年   588篇
  2016年   778篇
  2015年   1119篇
  2014年   1339篇
  2013年   1413篇
  2012年   1657篇
  2011年   1574篇
  2010年   1101篇
  2009年   992篇
  2008年   1080篇
  2007年   961篇
  2006年   829篇
  2005年   753篇
  2004年   638篇
  2003年   579篇
  2002年   520篇
  2001年   393篇
  2000年   282篇
  1999年   266篇
  1998年   167篇
  1997年   156篇
  1996年   129篇
  1995年   116篇
  1994年   97篇
  1993年   86篇
  1992年   102篇
  1991年   85篇
  1990年   57篇
  1989年   54篇
  1988年   37篇
  1987年   40篇
  1986年   35篇
  1985年   33篇
  1984年   8篇
  1983年   16篇
  1982年   15篇
  1981年   7篇
  1980年   5篇
  1977年   4篇
  1973年   2篇
  1967年   2篇
  1965年   2篇
  1951年   2篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
92.
This study investigated that dieckol (DKL), a natural drug, inhibits colon cancer cell proliferation and migration by inhibiting phosphoinositide-3-kinase (PI3K), protein kinase B (AKT), and mammalian target of rapamycin (mTOR) phosphorylation in HCT-116 cells. The cells were treated with DKL in various concentrations (32 and 50 μM) for 24 h and then analyzed for various experiments. MTT (tetrazolium bromide) and crystal violet assay investigated DKL-mediated cytotoxicity. Dichlorodihydrofluorescein diacetate staining was used to assess the reactive oxygen species (ROS) measurement, and apoptotic changes were studied by dual acridine orange and ethidium bromide staining. Protein expression of cell survival, cell cycle, proliferation, and apoptosis protein was evaluated by western blot analysis. Results indicated that DKL produces significant cytotoxicity in HCT-116, and the half-maximal inhibitory concentration was found to be 32 μM for 24-h incubation. Moreover, effective production of ROS and enhanced apoptotic signs were observed upon DKL treatment in HCT-116. DKL induces the expression of phosphorylated PI3K, AKT, and mToR-associated enhanced expression of cyclin-D1, proliferating cell nuclear antigen, cyclin-dependent kinase (CDK)-4, CDK-6, and Bcl-2 in HCT-116. In addition, proapoptotic proteins such as Bax, caspase-9, and caspase-3 were significantly enhanced by DKL treatment in HCT-116. Hence, DKL has been considered a chemotherapeutic drug by impeding the expression of PI3K-, AKT-, and mTOR-mediated inhibition of proliferation and cell cycle-regulating proteins.  相似文献   
93.
Vegetation and biomass in six plots, each with five quadrats, in Vitex shrubland in northern China were related to type and degree of human disturbance. Canonical correspondence analysis of the vegetation and environmental data showed two lines of variation, the first one highly correlated with the degree of disturbance, but the second one appearing within the disturbed plots cannot yet be fully explained. Changes in life-form spectrum were small, but the geographical spectrum changed under heavy disturbance towards a higher proportion of tropical, subtropical and cosmopolitan species. The number of shrub species also decreased noticeably. The above-ground biomass of both Vitex and the accompanying species and the total above-ground biomass of the shrubland was negatively correlated with the intensity of disturbance. The root/stem biomass ratio in Vitex reaches values of over 5 in disturbed plots, but only between 1 and 2 in the protected plots.  相似文献   
94.
95.
Acute liver failure (ALF) is an inflammation-mediated hepatocyte death process associated with ferroptosis. Avicularin (AL), a Chinese herbal medicine, exerts anti-inflammatory and antioxidative effects. However, the protective effect of AL and the mechanism on ALF have not been reported. Our in vivo results suggest that AL significantly alleviated lipopolysaccharide (LPS)/D-galactosamine (D-GalN)-induced hepatic pathological injury, liver enzymes, inflammatory cytokines, reactive oxygen species and iron levels and increased the antioxidant enzyme activities (malondialdehyde and glutathione). Our further in vitro experiments demonstrated that AL suppressed inflammatory response in LPS-stimulated RAW 264.7 cells via blocking the toll-like receptor 4 (TLR4)/myeloid differentiation protein-88 (MyD88)/nuclear factor kappa B (NF-κB) pathway. Moreover, AL attenuated ferroptosis in D-GalN-induced HepG2 cells by activating the nuclear factor erythroid 2-related factor 2 (Nrf2)/heme oxygenase 1 (HO-1)/glutathione peroxidase 4 (GPX4) pathway. Therefore, AL can alleviate inflammatory response and ferroptosis in LPS/D-GalN-induced ALF, and its protective effects are associated with blocking TLR4/MyD88/NF-κB pathway and activating Nrf2/HO-1/GPX4 pathway. Moreover, AL is a promising therapeutic option for ALF and should be clinically explored.  相似文献   
96.
A monoclonal antibody (H9724), specific for the 41-kDa flagellar protein of the Lyme disease pathogen Borrelia burgdorferi, cross-reacts with human axons and detects one major protein in human neuroblastoma cell extracts. The homologous cross-reacting protein has now been isolated from calf adrenal and identified as chaperonin-HSP60 by N-terminal sequencing.  相似文献   
97.
汉族ABO血型的皮纹特征分析   总被引:2,自引:1,他引:1  
作者对芜湖地区382例(男220人;女162人)汉族ABO血型的皮纹特征进行了分析,其中O型130人,A型113人,B型101人,AB型38人。分析比较了指纹类型、指纹组合格局、指嵴纹计数、掌嵴纹计数、atd角,掌部真实花纹,掌褶纹和拇趾球纹等项参数,结果表明,ABO各血型的皮纹参数间有若干统计学差异。  相似文献   
98.
用圆二色性谱来确定色氨酸阻遏物与其操纵基因复合物在溶液中的构象变化。色氨酸阻遏物的圆二色性图谱表明它是一种富含α螺旋的蛋白质,通过比较加入L-Trp前和后的圆二色性谱,发现活性的与非活性的色酸阻遏物二级结构变化很小,trp P/O的圆二色性谱与它的单健、双链理论计算曲线对比,可近拟推测操纵基因在溶液中的存在状态。用色氨酸阻遏物对trp P/O进行确定,可以从中找出蛋白质与核酸结合的平衡点。从平衡时  相似文献   
99.
理论上认为胆固醇逆向转运的速率与动脉粥样硬化程序呈负相关。但目前尚无完善的测试血浆脂蛋白-胆固醇体内代谢的方法。我们运用同位素^3H-胆固醇示踪方法,建立房室模型,选取健康兔与AS兔对照,研究血浆脂蛋白转运胆固醇能力的差异,并结合AS兔主动脉斑块程度对比,结果验证了上述理论,此法如改用短半衰期同位素或稳定性同位素标记的胆固醇,就可用于人体,这可为临床判断AS程度提供一种无创性的新方法。  相似文献   
100.
人胎肝细胞分泌的低分子抑瘤物对白血病细胞的抑制作用   总被引:4,自引:1,他引:3  
本工作证明了在胎儿组织中存在一类低分子天然肿瘤抑制物,它是胎儿组织细胞生成和分泌的,对瘤株细胞和原代白血病细胞有选择性抑制作用。初发期或复发期急性非淋巴细胞白血病患者的骨髓在体外液体培养条件下与肝细胞上清及其甲醇提取物共同孵育4d,可使所有病例的骨髓AML—CFU降低到不可检出的程度。因而,低分子天然抑瘤物是天然肿瘤免疫中的一个组成部分,它在肿瘤的诊断和治疗中有着深远的意义。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号